Levim Lifetech

Levim Lifetech is an India-based biopharmaceutical company focused on the development, manufacturing, and commercialization of biosimilars and complex biologics. The company utilizes advanced microbial expression systems, specifically Pichia pastoris and E. coli, to produce therapeutic proteins and peptides for metabolic and bone-related disorders. Their product portfolio includes biosimilar versions of insulin analogues and GLP-1 receptor agonists, targeting large markets such as diabetes and osteoporosis. Beyond its internal pipeline, Levim Lifetech provides comprehensive CDMO services, supporting partners from early-stage process development through to large-scale GMP manufacturing. The company aims to provide affordable, high-quality biological medicines to global markets.